These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 87887)

  • 41. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
    Guo F; Hirth JM; Berenson AB
    Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Confusion about Pap smears: lack of knowledge among high-risk women.
    Daley E; Perrin K; Vamos C; Hernandez N; Anstey E; Baker E; Kolar S; Ebbert J
    J Womens Health (Larchmt); 2013 Jan; 22(1):67-74. PubMed ID: 23215902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
    Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
    Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark.
    Olesen F
    Int J Epidemiol; 1988 Sep; 17(3):501-8. PubMed ID: 3209326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to screening for cancer of the cervix.
    Peters RK; Bear MB; Thomas D
    Prev Med; 1989 Jan; 18(1):133-46. PubMed ID: 2710757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smear misclassification in a cervical cancer screening programme.
    Lynge E; Arffmann E; Poll P; Anderson PK
    Br J Cancer; 1993 Aug; 68(2):368-73. PubMed ID: 8347493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of Pap smear and its influencing factors among women with disabilities in Taiwan.
    Huang KH; Tsai WC; Kung PT
    Res Dev Disabil; 2012; 33(2):307-14. PubMed ID: 22100350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knowledge, attitude and practice of the pap smear as a screening procedure among nurses in a tertiary hospital in north eastern India.
    Thippeveeranna C; Mohan SS; Singh LR; Singh NN
    Asian Pac J Cancer Prev; 2013; 14(2):849-52. PubMed ID: 23621250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
    Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
    Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors related to poor practice of Pap smear screening among secondary school teachers in Malaysia.
    Abdullah F; Aziz NA; Su TT
    Asian Pac J Cancer Prev; 2011; 12(5):1347-52. PubMed ID: 21875295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the pap smear test status of Turkish women and related factors.
    Karabulutlu O
    Asian Pac J Cancer Prev; 2013; 14(2):981-6. PubMed ID: 23621272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.